BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 27281560)

  • 1. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
    Geng F; Cheng X; Wu X; Yoo JY; Cheng C; Guo JY; Mo X; Ru P; Hurwitz B; Kim SH; Otero J; Puduvalli V; Lefai E; Ma J; Nakano I; Horbinski C; Kaur B; Chakravarti A; Guo D
    Clin Cancer Res; 2016 Nov; 22(21):5337-5348. PubMed ID: 27281560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOAT1: A Suitable Target for Therapy in High-Grade Astrocytic Glioma?
    Löhr M; Härtig W; Schulze A; Kroiß M; Sbiera S; Lapa C; Mages B; Strobel S; Hundt JE; Bohnert S; Kircher S; Janaki-Raman S; Monoranu CM
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage.
    Kou Y; Geng F; Guo D
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth.
    Ru P; Hu P; Geng F; Mo X; Cheng C; Yoo JY; Cheng X; Wu X; Guo JY; Nakano I; Lefai E; Kaur B; Chakravarti A; Guo D
    Cell Rep; 2016 Aug; 16(6):1527-1535. PubMed ID: 27477273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid droplets, potential biomarker and metabolic target in glioblastoma.
    Geng F; Guo D
    Intern Med Rev (Wash D C); 2017 May; 3(5):. PubMed ID: 29034362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
    Guo D; Reinitz F; Youssef M; Hong C; Nathanson D; Akhavan D; Kuga D; Amzajerdi AN; Soto H; Zhu S; Babic I; Tanaka K; Dang J; Iwanami A; Gini B; Dejesus J; Lisiero DD; Huang TT; Prins RM; Wen PY; Robins HI; Prados MD; Deangelis LM; Mellinghoff IK; Mehta MP; James CD; Chakravarti A; Cloughesy TF; Tontonoz P; Mischel PS
    Cancer Discov; 2011 Oct; 1(5):442-56. PubMed ID: 22059152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic effects of phytol and retinol on human glioblastoma cells are associated with modulation of cholesterol and fatty acid biosynthetic pathways.
    Facchini G; Ignarro RS; Rodrigues-Silva E; Vieira AS; Lopes-Cendes I; Castilho RF; Rogerio F
    J Neurooncol; 2018 Feb; 136(3):435-443. PubMed ID: 29159775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis.
    Liu Y; Hua W; Li Y; Xian X; Zhao Z; Liu C; Zou J; Li J; Fang X; Zhu Y
    Biochem Pharmacol; 2020 Apr; 174():113776. PubMed ID: 31874145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SREBP-1 upregulates lipophagy to maintain cholesterol homeostasis in brain tumor cells.
    Geng F; Zhong Y; Su H; Lefai E; Magaki S; Cloughesy TF; Yong WH; Chakravarti A; Guo D
    Cell Rep; 2023 Jul; 42(7):112790. PubMed ID: 37436895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 25-hydroxycholesterol on cholesterol esterification and sterol regulatory element-binding protein processing are dissociable: implications for cholesterol movement to the regulatory pool in the endoplasmic reticulum.
    Du X; Pham YH; Brown AJ
    J Biol Chem; 2004 Nov; 279(45):47010-6. PubMed ID: 15317807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting SREBP-1-driven lipid metabolism to treat cancer.
    Guo D; Bell EH; Mischel P; Chakravarti A
    Curr Pharm Des; 2014; 20(15):2619-26. PubMed ID: 23859617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6.
    Guan M; Fousek K; Jiang C; Guo S; Synold T; Xi B; Shih CC; Chow WA
    Clin Cancer Res; 2011 Apr; 17(7):1796-806. PubMed ID: 21355074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different kinetics of cholesterol delivery to components of the cholesterol homeostatic machinery: implications for cholesterol trafficking to the endoplasmic reticulum.
    Kristiana I; Yang H; Brown AJ
    Biochim Biophys Acta; 2008; 1781(11-12):724-30. PubMed ID: 18838129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-1 protease, a novel metabolic target for glioblastoma.
    Caruana BT; Skoric A; Brown AJ; Lutze-Mann LH
    Biochem Biophys Res Commun; 2017 Aug; 490(3):760-766. PubMed ID: 28645614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme.
    Lewis CA; Brault C; Peck B; Bensaad K; Griffiths B; Mitter R; Chakravarty P; East P; Dankworth B; Alibhai D; Harris AL; Schulze A
    Oncogene; 2015 Oct; 34(40):5128-40. PubMed ID: 25619842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 27-Hydroxycholesterol Inhibits Sterol Regulatory Element-Binding Protein 1 Activation and Hepatic Lipid Accumulation in Mice.
    Li D; Long W; Huang R; Chen Y; Xia M
    Obesity (Silver Spring); 2018 Apr; 26(4):713-722. PubMed ID: 29476609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrient sensor O-GlcNAc transferase controls cancer lipid metabolism via SREBP-1 regulation.
    Sodi VL; Bacigalupa ZA; Ferrer CM; Lee JV; Gocal WA; Mukhopadhyay D; Wellen KE; Ivan M; Reginato MJ
    Oncogene; 2018 Feb; 37(7):924-934. PubMed ID: 29059153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of sterol O-acyltransferase 1 (SOAT1) suppresses SCD1-mediated lipogenesis and cancer procession in prostate cancer.
    Liu Y; Wang Y; Hao S; Qin Y; Wu Y
    Prostaglandins Other Lipid Mediat; 2021 Apr; 153():106537. PubMed ID: 33454379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic cholesterol esterification is regulated by a cyclic AMP-dependent pathway in yolk sac membrane-derived endodermal epithelial cells.
    Wang SH; Lin HJ; Lin YY; Chen YJ; Pan YH; Tung CT; Mersmann HJ; Ding ST
    PLoS One; 2017; 12(11):e0187560. PubMed ID: 29161294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid metabolism reprogramming and its potential targets in cancer.
    Cheng C; Geng F; Cheng X; Guo D
    Cancer Commun (Lond); 2018 May; 38(1):27. PubMed ID: 29784041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.